MedTrace Logo

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

NCT01812525 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-08-19

No results posted yet for this study

Summary

Our study will investigate inhalation therapy of NaCl 3% compared to standard therapy with no inhalation in the treatment of moderate to severe bronchiolitis. The impact on length of hospital stay will be analyzed.

Conditions

  • Moderate to Severe Bronchiolitis

Interventions

DRUG

NaCl 3%

NaCl 3%: 4ml QID

OTHER

Standard therapy

Standard therapy includes suctioning nasal secretions, water-electrolyte balance maintenance and oxygen supplementation when needed

Sponsors & Collaborators

  • Swiss Foundation for the Health of Children and Adolescents

    collaborator OTHER

  • Raphaelle Jaquet-Pilloud

    lead OTHER

Principal Investigators

  • Jean-Yves Pauchard · Hôpital de l'Enfance, Lausanne, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812525 on ClinicalTrials.gov